Latest News and Press Releases

Austin, TX, USA, May 14, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Transgenic Animals Market Size, Trends and Insights By Type (Mice, Rats, Rabbits,...

BERKELEY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced that Caribou’s...

Kraig Biocraft Laboratories (OTCQB:KBLB) has the materials science answer to the global plastics crisis

BERKELEY, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced two abstracts...

Kraig Biocraft Laboratories (OTCQB: KBLB) successfully commissioned another recombinant spider silk production rearing center.

-- Achieved alignment with FDA on pivotal ANTLER-3 trial design for vispa-cel in 2L LBCL -- -- Longer follow up on vispa-cel phase 1 clinical data expected at medical conference in 2026 -- --...

Kraig Labs (OTCQB: KBLB) is the leader in the global race to commercialize spider silk, validated science and advancing production capability.

BERKELEY, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel...

Kraig Labs (OTCQB: KBLB) officially launched its next production cycle following the Company's recent record-setting production run.

Kraig Labs (OTCQB: KBLB) two major milestones signal accelerating momentum toward the first successful spider silk commercialization